Molecular mechanisms of novel therapeutic approaches for multiple myelomaTeru Hideshima(Harvard University), Kenneth C. Anderson(Dana-Farber Cancer Institute)Nature reviews. CancerDecember 1, 200210.1038/nrc952Cited by 425SaveCiteExport RISWatch citationsAbstractRelated PapersCell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell LinesJason S. Damiano, Anne E. Cress, Lori Hazlehurst et al.|Blood|1999|862Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa BDharminder Chauhan, Hiroshi Uchiyama, Yasmin Akbarali et al.|Blood|1996|566High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical TrialJean‐Paul Fermand, Philippe Ravaud, Sylvie Chevret et al.|Blood|1998|539Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretionHiroshi Uchiyama, BA Barut, AF Mohrbacher et al.|Blood|1993|419IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascadeAtsushi Ogata, Dharminder Chauhan, Gerrard Teoh et al.|The Journal of Immunology|1997|407